Post-injury Administration of NAAG Peptidase Inhibitor Prodrug, PGI-02776, in Experimental TBI

Por Feng, Jun-Feng, Van, Ken C., Gurkoff, Gene G., Kopriva, Christina, Olszewski, Rafal T., Song, Minsoo, Sun, Shifeng, Xu, Man, Neale, Joseph H., Yuen, Po-Wai, Lowe, David A., Zhou, Jia, Lyeth, Bruce G.
Publicado em 2011

Chemistry and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile

Por Zhang, Hankun, Tückmantel, Werner, Eaton, J. Brek, Yuen, Po-wai, Yu, Li-Fang, Bajjuri, Krishna Mohan, Fedolak, Allison, Wang, Daguang, Ghavami, Afshin, Caldarone, Barbara, Paterson, Neil E., Lowe, David A., Brunner, Daniela, Lukas, Ronald J., Kozikowski, Alan P.
Publicado em 2012

GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile

Por Villemure, Elisia, Volgraf, Matthew, Jiang, Yu, Wu, Guosheng, Ly, Cuong Q., Yuen, Po-wai, Lu, Aijun, Luo, Xifeng, Liu, Mingcui, Zhang, Shun, Lupardus, Patrick J., Wallweber, Heidi J. A., Liederer, Bianca M., Deshmukh, Gauri, Plise, Emile, Tay, Suzanne, Wang, Tzu-Ming, Hanson, Jesse E., Hackos, David H., Scearce-Levie, Kimberly, Schwarz, Jacob B., Sellers, Benjamin D.
Publicado no ACS Med Chem Lett (2016)